Crescent Capital BDC, Inc. (NASDAQ:CCAP) Receives $18.80 Average PT from Analysts

Shares of Crescent Capital BDC, Inc. (NASDAQ:CCAP) have earned a consensus rating of “Moderate Buy” from the six brokerages that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $19.00.

Several analysts have recently weighed in on the company. Bank of America decreased their price objective on Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating on the stock in a report on Thursday, August 15th. LADENBURG THALM/SH SH assumed coverage on Crescent Capital BDC in a report on Monday, September 30th. They set a “buy” rating and a $20.00 price objective on the stock. Finally, Wells Fargo & Company cut their target price on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 14th.

Hedge Funds Weigh In On Crescent Capital BDC

Several hedge funds and other institutional investors have recently modified their holdings of CCAP. Point72 Asset Management L.P. bought a new position in Crescent Capital BDC in the 2nd quarter valued at $90,000. Tucker Asset Management LLC bought a new position in Crescent Capital BDC in the 4th quarter valued at $167,000. XTX Topco Ltd bought a new position in Crescent Capital BDC in the 2nd quarter valued at $195,000. Alpine Global Management LLC bought a new position in Crescent Capital BDC in the 1st quarter valued at $217,000. Finally, Catalina Capital Group LLC bought a new position in Crescent Capital BDC in the 2nd quarter valued at $220,000. Institutional investors own 49.46% of the company’s stock.

Crescent Capital BDC Price Performance

Shares of NASDAQ:CCAP opened at $18.30 on Monday. Crescent Capital BDC has a 1-year low of $15.03 and a 1-year high of $19.63. The firm has a market capitalization of $678.23 million, a PE ratio of 6.51 and a beta of 0.81. The business’s 50 day moving average is $18.34 and its 200-day moving average is $18.18. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.17.

Crescent Capital BDC (NASDAQ:CCAP) last announced its quarterly earnings data on Monday, August 12th. The company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.58 by $0.01. Crescent Capital BDC had a return on equity of 12.03% and a net margin of 51.61%. The company had revenue of $48.95 million for the quarter, compared to analyst estimates of $48.05 million. During the same quarter last year, the firm earned $0.56 EPS. Sell-side analysts predict that Crescent Capital BDC will post 2.34 earnings per share for the current year.

Crescent Capital BDC Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Monday, September 30th will be given a dividend of $0.42 per share. This represents a $1.68 annualized dividend and a dividend yield of 9.18%. The ex-dividend date of this dividend is Monday, September 30th. This is an increase from Crescent Capital BDC’s previous quarterly dividend of $0.09. Crescent Capital BDC’s dividend payout ratio (DPR) is 59.79%.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.